$MLRT
Metalert, Inc. Stock $mlrt

$mlrt Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000149315223012525 Filed on April 17, 2023

Income Statement

Concept	2023 Q2	2022 Q4	2022
Revenue	$48.84K	$34.04K	$334.6K
YoY Change	-24.17%	-28.73%	-43.23%
Cost Of Revenue	$43.31K	$26.59K	$189.8K
YoY Change	3.22%	-62.33%	-43.22%
Gross Profit	$5.526K	$7.450K	$144.8K
YoY Change	-75.37%	-132.65%	-43.25%
Gross Profit Margin	11.31%	21.89%	43.29%
Selling, General & Admin	$178.5K	$691.0K	$248.8K
YoY Change	451.72%	157.85%	-22.41%
% of Gross Profit	3229.82%	9274.9%	171.76%
Research & Development			$18.96K
YoY Change			1379.02%
% of Gross Profit			13.09%
Depreciation & Amortization	$8.330K	$33.34K	$33.34K
YoY Change	0.0%	299.76%	115.96%
% of Gross Profit	150.74%	447.52%	23.02%
Operating Expenses	$186.8K	$699.3K	$1.515M
YoY Change	-22.43%	153.08%	30.65%
Operating Profit	-$181.3K	-$691.9K	-$1.370M
YoY Change	-17.0%	131.28%	51.5%
Interest Expense		-$55.17K	-$172.7K
YoY Change		110.57%	53.1%
% of Operating Profit
Other Income/Expense, Net	-$27.29K	-$100.9K	-$132.7K
YoY Change	249.33%	-44.92%	-55.15%
Pretax Income	-$208.6K	-$780.0K	-$1.503M
YoY Change	-7.8%	76.31%	25.21%
Income Tax
% Of Pretax Income
Net Earnings	-$208.6K	-$780.0K	-$1.503M
YoY Change	-7.8%	76.31%	25.21%
Net Earnings / Revenue	-427.08%	-2291.48%	-449.21%
Basic Earnings Per Share	-$0.02		-$0.21
Diluted Earnings Per Share	-$0.02	-$0.05	-$0.21
COMMON SHARES
Basic Shares Outstanding	22.83M shares	15.57M shares	7.197M shares
Diluted Shares Outstanding	22.90M shares		7.197M shares

Balance Sheet

Concept	2023 Q2	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$45.74K	$9.220K	$9.220K
YoY Change	-26.62%	-93.45%	-93.45%
Cash & Equivalents	$45.09K	$8.534K	$8.530K
Short-Term Investments	$650.00	$680.00	$680.00
Other Short-Term Assets	$4.770K	$8.045K	$8.050K
YoY Change	-78.58%	-85.38%	-85.37%
Inventory	$56.46K	$70.11K	$70.11K
Prepaid Expenses
Receivables	$12.92K	$13.96K	$13.96K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$119.9K	$101.3K	$101.3K
YoY Change	-31.2%	-67.08%	-67.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$42.45K	$59.12K	$59.12K
YoY Change	-43.99%	-36.06%	-36.06%
Goodwill
YoY Change
Intangibles	$3.308K	$3.308K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$45.76K	$62.43K	$62.43K
YoY Change	-39.63%	-32.48%	-32.48%
TOTAL ASSETS
Total Short-Term Assets	$119.9K	$101.3K	$101.3K
Total Long-Term Assets	$45.76K	$62.43K	$62.43K
Total Assets	$165.7K	$163.8K	$163.8K
YoY Change	-33.75%	-59.09%	-59.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$165.2K	$137.3K	$137.3K
YoY Change	35.11%	-24.8%	-12.47%
Accrued Expenses	$226.4K	$388.4K	$886.0K
YoY Change	-34.54%	18.67%	-18.4%
Deferred Revenue	$6.550K	$12.85K
YoY Change	-65.71%	-65.6%
Short-Term Debt	$2.539M	$2.209M	$2.209M
YoY Change	42.62%		24.43%
Long-Term Debt Due	$111.2K	$89.55K	$89.55K
YoY Change	197.62%	9.27%	9.27%
Total Short-Term Liabilities	$3.734M	$3.335M	$3.335M
YoY Change	18.26%	6.3%	6.3%
LONG-TERM LIABILITIES
Long-Term Debt	$139.6K	$142.1K	$142.1K
YoY Change	-3.51%	-0.57%	-0.57%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$139.6K	$142.1K	$142.1K
YoY Change	-3.51%	-0.57%	-0.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.734M	$3.335M	$3.335M
Total Long-Term Liabilities	$139.6K	$142.1K	$142.1K
Total Liabilities	$3.874M	$3.477M	$3.477M
YoY Change	17.31%	6.0%	6.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$28.01M	-$27.56M
YoY Change	5.82%	5.77%
Common Stock	$2.341K	$1.718K
YoY Change	-90.53%	-92.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.708M	-$3.313M	-$3.313M
YoY Change
Total Liabilities & Shareholders Equity	$165.7K	$163.8K	$163.8K
YoY Change	-33.75%	-59.09%	-59.09%

Cashflow Statement

Concept	2023 Q2	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$208.6K	-$780.0K	-$1.503M
YoY Change	-7.8%	76.31%	25.21%
Depreciation, Depletion And Amortization	$8.330K	$33.34K	$33.34K
YoY Change	0.0%	299.76%	115.96%
Cash From Operating Activities	-$106.5K	-$507.0K	-$507.0K
YoY Change	-16.79%	323.69%	1.86%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$3.310K	-$3.310K
YoY Change			-362.7%
Cash From Investing Activities	$0.00	-$3.310K	-$3.308K
YoY Change		-90.68%	-96.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	146.9K	380.5K	$380.5K
YoY Change	1.86%		-42.17%
NET CHANGE
Cash From Operating Activities	-106.5K	-507.0K	-$507.0K
Cash From Investing Activities	0.000	-3.310K	-$3.308K
Cash From Financing Activities	146.9K	380.5K	$380.5K
Net Change In Cash	40.42K	-129.8K	-$129.8K
YoY Change	148.89%	-16.34%	-311.31%
FREE CASH FLOW
Cash From Operating Activities	-$106.5K	-$507.0K	-$507.0K
Capital Expenditures
Free Cash Flow			-$507.0K
YoY Change			-15.18%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001375793
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2021Q4	MLRT	Notes Payable Related Parties NotesPayableRelatedParties		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021	MLRT	Care Edd Forgiveness CareEddForgiveness		usd
CY2022	MLRT	Loss On Conversion Of Debt LossOnConversionOfDebt		usd
CY2022	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends		usd
CY2021	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends		usd
CY2022	MLRT	Redeemable Preferred Stock Dividends One RedeemablePreferredStockDividendsOne		usd
CY2021	MLRT	Issuance Of Common Stock For Conversion Of Warrants1 IssuanceOfCommonStockForConversionOfWarrants1		usd
CY2021	MLRT	Issuance Of Preferred Stock IssuanceOfPreferredStock		usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings		usd
CY2022	MLRT	Stock Returned During Period Value Preferred A Stock To Treasury StockReturnedDuringPeriodValuePreferredAStockToTreasury		usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts		usd
CY2022	MLRT	Adjustments For Bonus Shares Issued To Noteholders AdjustmentsForBonusSharesIssuedToNoteholders		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty		usd
CY2022	MLRT	Interest Added To Convertible Note Balance InterestAddedToConvertibleNoteBalance		usd
CY2021	MLRT	Interest And Financing Costs On Long Term Convertible Debt InterestAndFinancingCostsOnLongTermConvertibleDebt		usd
CY2021	MLRT	Grant From Care Loans GrantFromCareLoans		usd
CY2021	MLRT	Loans To From Officers LoansToFromOfficers		usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2021	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	MLRT	Noncash Debt Discount On Notes Convertible NoncashDebtDiscountOnNotesConvertible		usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2022	MLRT	Deemed Dividend DeemedDividend		usd
CY2022	MLRT	Noncash Conversion Of Accrued Interest NoncashConversionOfAccruedInterest		usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross		usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization		usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization		usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2021Q4	us-gaap	Other Borrowings OtherBorrowings		usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent		usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent		usd
CY2022Q4	MLRT	Paycheck Protection Program Loan Amount PaycheckProtectionProgramLoanAmount		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	MLRT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2022	MLRT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-53046
CY2022	dei	Entity Registrant Name EntityRegistrantName	MetAlert Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0493446
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	117 W 9th Street
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1214
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90015
CY2022	dei	City Area Code CityAreaCode	213
CY2022	dei	Local Phone Number LocalPhoneNumber	489-3019
CY2022	dei	Security12b Title Security12bTitle	None
CY2022	dei	Trading Symbol TradingSymbol	MLRT
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	10156	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	22833465	shares
CY2022	dei	Auditor Name AuditorName	M&K CPAS, PLLC
CY2022	dei	Auditor Location AuditorLocation	Houston, Texas
CY2022	dei	Auditor Firm AuditorFirmId	2738
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8534	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	138342	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	13959	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	13735	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	70112	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	98258	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	683	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2465	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	8045	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	55016	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	101333	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	307816	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3308	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	59121	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	92461	usd
CY2022Q4	us-gaap	Assets Assets	163762	usd
CY2021Q4	us-gaap	Assets Assets	400277	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	137315	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	156886	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	388414	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	298662	usd
CY2022Q4	MLRT	Accrued Expenses Related Parties Current AccruedExpensesRelatedPartiesCurrent	497551	usd
CY2021Q4	MLRT	Accrued Expenses Related Parties Current AccruedExpensesRelatedPartiesCurrent	787044	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	12850	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	37250	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	81651	usd
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	7000	usd
CY2022Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	7903	usd
CY2021Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	74953	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	843000	usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	758000	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1206738	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	976546	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	149120	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	40640	usd
CY2022Q4	MLRT	Notes Payable Related Parties NotesPayableRelatedParties	10000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3334542	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3136981	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	142097	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	142917	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3476639	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3279898	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2071000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2071000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17177206	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17177206	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3453885	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3453885	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1718	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	345	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24241862	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23173317	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27556471	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26053384	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3312877	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2879621	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	163762	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	400277	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	334606	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	589440	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	189758	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	334186	usd
CY2022	us-gaap	Gross Profit GrossProfit	144848	usd
CY2021	us-gaap	Gross Profit GrossProfit	255254	usd
CY2022	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	509064	usd
CY2021	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	501544	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	757371	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	337627	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	22733	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	75391	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	226055	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	245238	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1515223	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	1159800	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1370375	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-904546	usd
CY2022	MLRT	Loss On Marketable Securities LossOnMarketableSecurities	-1782	usd
CY2021	MLRT	Loss On Marketable Securities LossOnMarketableSecurities	-443	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	62067	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	30705	usd
CY2022	MLRT	Care Edd Forgiveness CareEddForgiveness	102061	usd
CY2021	MLRT	Loss On Conversion Of Debt LossOnConversionOfDebt	-152406	usd
CY2022	MLRT	Interest Expense Income And Financing Costs InterestExpenseIncomeAndFinancingCosts	-170924	usd
CY2021	MLRT	Interest Expense Income And Financing Costs InterestExpenseIncomeAndFinancingCosts	-112358	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-132712	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-295912	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1503087	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1200458	usd
CY2021	MLRT	Redeemable Preferred Stock Dividends One RedeemablePreferredStockDividendsOne	675000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1503087	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1875458	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7197291	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2839586	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.66
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-3077195	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	240239	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	192733	usd
CY2021	MLRT	Proceeds From Issuance Of Preferred Stock For Financing ProceedsFromIssuanceOfPreferredStockForFinancing	-675000	usd
CY2021	MLRT	Issuance Of Common Stock For Conversion Of Warrants IssuanceOfCommonStockForConversionOfWarrants	-3250	usd
CY2021	MLRT	Adjustment To Additional Paid In Capital Imputed Interest Related Parties AdjustmentToAdditionalPaidInCapitalImputedInterestRelatedParties	30705	usd
CY2021	MLRT	Shares Issued For Conversion Of Debt SharesIssuedForConversionOfDebt	218106	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	38000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1200458	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2879621	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	621246	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	114062	usd
CY2022	MLRT	Issuance Of Common Stock For Financings IssuanceOfCommonStockForFinancings	180000	usd
CY2022	MLRT	Issuance Of Common Stock For Conversion Of Warrants IssuanceOfCommonStockForConversionOfWarrants	25001	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	129522	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1503087	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3312877	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1503087	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1200458	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	33340	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	15438	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	28323	usd
CY2022	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-1782	usd
CY2021	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-443	usd
CY2022	MLRT	Fair Value Of Common Stock Issued For Services FairValueOfCommonStockIssuedForServices	621246	usd
CY2021	MLRT	Fair Value Of Common Stock Issued For Services FairValueOfCommonStockIssuedForServices	263135	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	62067	usd
CY2021	MLRT	Adjustments For Bonus Shares Issued To Noteholders AdjustmentsForBonusSharesIssuedToNoteholders	3275	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-152406	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2340	usd
CY2021	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	30705	usd
CY2021	MLRT	Interest Added To Convertible Note Balance InterestAddedToConvertibleNoteBalance	102040	usd
CY2022	MLRT	Interest And Financing Costs On Long Term Convertible Debt InterestAndFinancingCostsOnLongTermConvertibleDebt	116641	usd
CY2022	MLRT	Grant From Care Loans GrantFromCareLoans	67870	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	224	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1574	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-28146	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-15879	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-47241	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	328	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	270	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	95	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	29086	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-43022	usd
CY2022	MLRT	Increase Decrease In Account Payable Related Parties IncreaseDecreaseInAccountPayableRelatedParties	139352	usd
CY2021	MLRT	Increase Decrease In Account Payable Related Parties IncreaseDecreaseInAccountPayableRelatedParties	133909	usd
CY2022	MLRT	Loans To From Officers LoansToFromOfficers	10000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-24400	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-100	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-506950	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-497684	usd
CY2022	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	3308	usd
CY2021	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	-1258	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	100021	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3308	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-98763	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	25000	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	180000	usd
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	675000	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	145000	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	144118	usd
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	2123	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	44201	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	69467	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	15000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	380450	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	657877	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-129808	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	61430	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	138342	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	76912	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8534	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	138342	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	623	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	238124	usd
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	149373	usd
CY2021	MLRT	Noncash Debt Discount On Notes Convertible NoncashDebtDiscountOnNotesConvertible	38000	usd
CY2022	MLRT	Transfer Of Convertible Related Party Debt TransferOfConvertibleRelatedPartyDebt	100000	usd
CY2021	MLRT	Transfer Of Convertible Related Party Debt TransferOfConvertibleRelatedPartyDebt	70000	usd
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	3800	usd
CY2021	MLRT	Deemed Dividend DeemedDividend	675000	usd
CY2021	MLRT	Noncash Conversion Of Accrued Interest NoncashConversionOfAccruedInterest	109230	usd
CY2022	MLRT	Related Party Accrued Expenses To Convertible Debt Related Party RelatedPartyAccruedExpensesToConvertibleDebtRelatedParty	706248	usd
CY2021	MLRT	Related Party Accrued Expenses To Convertible Debt Related Party RelatedPartyAccruedExpensesToConvertibleDebtRelatedParty	200000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1503087	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27556471	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3312877	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	334606	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	589440	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	334606	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	589440	usd
CY2022	us-gaap	Depreciation Depreciation	33340	usd
CY2021	us-gaap	Depreciation Depreciation	15438	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	12431	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	40351	usd
CY2022	us-gaap	Standard Product Warranty Description StandardProductWarrantyDescription	The Company’s warranty policy provides repair or replacement of products (excluding GPS Shoe devices) returned for defects within ninety days of purchase.
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zCrsdOvt8kn2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_864_zS69t4DFeVqe">Use of Estimates</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Material estimates relate to the assumptions made in determining reserves for uncollectible receivables, inventory reserves and returns, impairment analysis of long-term assets and deferred tax assets, accruals for potential liabilities and assumptions made in valuing the fair market value of equity transactions. Estimates are updated on an ongoing basis and are evaluated based on historical experience and current circumstances. Changes in facts and circumstances in the future may give rise to changes in these estimates which may cause actual results to differ from current estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	776923	shares
CY2021	MLRT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice	0.16
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	361538	shares
CY2022	us-gaap	Property Plant And Equipment Estimated Useful Lives PropertyPlantAndEquipmentEstimatedUsefulLives	three-year
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18961	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1282	usd
CY2021	MLRT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice	2.60
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	346154	shares
CY2021	MLRT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice	0.65
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	3846	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	757693	shares
CY2022	MLRT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice	0.16
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	153847	shares
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zDSWuMp3djfe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86D_zvMxpdcdNXF2">Concentrations</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We currently rely on one manufacturer to supply us with our GPS SmartSole and one manufacturer to supply us with the GPS device included in the GPS SmartSole. The loss of either of these manufacturers could severely impede our ability to manufacture the GPS SmartSole.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the Company had four customers representing approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zOJmw6S8HRti">28</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_z0uw1QDPj53f">21</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zWTWKCVhGdE2">15</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zgsmacnHT7Q6">95</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of sales and three customers representing approximately <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z8Ehe5GaETQl">50</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zBShVt7XZ4N4">22</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, and </span><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_z6kRUpACtXKe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of total accounts receivable, respectively. The Company had three customers representing approximately </span><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zoJf88eyldPa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, </span><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zIvxsMiD5bu1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% and </span><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zII4Dc7Y3ZUb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of sales and four customers representing approximately </span><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zCvp2TIiI3Hf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, </span><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zrQrFmGwRA7l" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, </span><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zztFRo7Vhhsf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% and </span><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zptsEOMU3Mte" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of total accounts receivable, respectively, for the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	111615077	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	89060506	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	603846	shares
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2022	MLRT	Investment Owned Description InvestmentOwnedDescription	The Company’s investments in marketable securities is comprised of shares of stock of two (2) entities with ownership percentages of less than 5%. The Company accounted for these investments pursuant to ASU 320, Investments – Debt and Equity Securities. As such, these investments were recorded at their market value as of December 31, 2019, with the change in fair value being reflected in the statement of operations.
CY2019	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	10889	shares
CY2020	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	8500	shares
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	51531	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	72936	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	18581	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	25322	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	70112	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	98258	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	454913	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	421573	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	59121	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	92461	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3308	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3308	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	0	usd
CY2021	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	0	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	149120	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	40640	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	7000	usd
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	7000	usd
CY2022Q4	us-gaap	Other Borrowings OtherBorrowings	74651	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	230771	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	47640	usd
CY2022Q2	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	25000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	120000	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	843000	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	758000	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	843000	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	758000	usd
CY2021Q4	MLRT	Paycheck Protection Program Loan Amount PaycheckProtectionProgramLoanAmount	67870	usd
CY2022Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	7903	usd
CY2021Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	7083	usd
CY2022Q4	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	142097	usd
CY2021Q4	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	142917	usd
CY2022Q4	MLRT	Short Term And Long Term Loans Payable ShortTermAndLongTermLoansPayable	150000	usd
CY2021Q4	MLRT	Short Term And Long Term Loans Payable ShortTermAndLongTermLoansPayable	217870	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	200000	usd
CY2021	MLRT	Due To Related Parties Amount Converted Into Notes DueToRelatedPartiesAmountConvertedIntoNotes	200000	usd
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	423743	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	470375	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	87257	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	167625	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-226000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-73000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-2517000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-2408000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2232000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1843000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4066525	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3891095	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4066525	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3891095	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	19362715	usd
CY2022	MLRT	Income Tax Expiration IncomeTaxExpiration	2028
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	940349	usd
CY2022	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	13723321	shares
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	460783	usd
CY2021	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	1330322	shares
CY2022	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-75 reverse stock split
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021Q4	MLRT	Bonus Declared Or Accrued BonusDeclaredOrAccrued	0	usd
CY2022Q4	MLRT	Bonus Declared Or Accrued BonusDeclaredOrAccrued	0	usd

Files In Submission

Name	View Source	Status
0001493152-23-012525-index-headers.html	Edgar Link	pending
0001493152-23-012525-index.html	Edgar Link	pending
0001493152-23-012525.txt	Edgar Link	pending
0001493152-23-012525-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mlrt-20221231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
mlrt-20221231_cal.xml	Edgar Link	unprocessable
mlrt-20221231_def.xml	Edgar Link	unprocessable
mlrt-20221231_lab.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
mlrt-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MLRT
Metalert, Inc. Stock $mlrt

2023 Q2 Form 10-K Financial Statement

#000149315223012525 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLRT Metalert, Inc. Stock $mlrt

2023 Q2 Form 10-K Financial Statement

#000149315223012525 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLRT
Metalert, Inc. Stock $mlrt